HMOX1 and periodontal disorder: The results of the present study demonstrate for the first time that the anti-inflammatory effects of CORM-3 occur via HO-1-dependent pathways in periodontal disease models, and these pathways are mediated through VE-cadherin, ZO-1, and β-catenin expressions.